Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Clinical Trial Biorepository & Archiving Solutions Market Snapshot (2022-2032)

[250 Pages Report] Newly-released Clinical Trial Biorepository & Archiving Solutions Market analysis report by Future Market Insights shows that global sales of Clinical Trial Biorepository & Archiving Solutions Market in 2021 was held at US$ 3.5 Billion. With 12.1%, the projected market growth during 2022 to 2032 is expected to be significantly higher than the historical growth. Clinical Products are expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 11.9% from 2022 to 2032.

Attributes Details
Clinical Trial Biorepository & Archiving Solutions Market CAGR (2022 to 2032) 12.1%
Clinical Trial Biorepository & Archiving Solutions Market Size (2022) US$ 3.9 Billion
Clinical Trial Biorepository & Archiving Solutions Market Size (2032) US$ 12.2 Billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of Clinical Trial Biorepository & Archiving Solutions Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

According to the Clinical Trial Biorepository & Archiving Solutions Market research conducted by Future Market Insights, market research and competitive intelligence provider, the market value of the Clinical Trial Biorepository & Archiving Solutions Market increased at a CAGR of around 12.1% from 2017 to 2021.

The market growth is mainly due to the enhancement in the fields of depersonalized and genomic medicine. Also, the push to streamline data collecting and reporting by adopting software such as Laboratory Information Management for laboratory sample tests have been augmenting the market growth. The UB Biorepository is a key new institution at the Clinical and Experimental Research Center that will be a vital resource in advancing biomedical innovations in academics and businesses. The center has the potential to gather, analyze, preserve, and disseminate millions of tissue samples, allowing UB and its academic and commercial partners to utilize the findings that will eventually help patients.

The clinical products category held the largest market share with a CAGR of 11.9% in 2021 and earned more revenue than other product types. Cell & Co., a company that provides biorepository and transport services for the life science sector was incorporated in 2012 and reported sales of over 2.6 million Euros in 2021.

Big data have made inroads in biorepositories, which are mainly focused on the use of modern information technologies for storage, to be interpreted with artificial intelligence, machine learning, and also deep learning tools and algorithms. Tech companies are seeking to disrupt the traditional method of conducting clinical trials.

What Factors are Propelling Clinical Trial Biorepository & Archiving Solutions Demand?

The attempt to modernize clinical trials involves extracting voluminous information through healthcare data, integrating telehealth in decentralized studies done partially or wholly digitally to attract a broader range of respondents, and using devices to collect additional data.

The market is growing at a fast pace due to the increased availability of low-cost devices and also the desire to build data compilation and easy reporting by using software similar to a laboratory information management system, which is mainly made to be used by the management of samples in laboratories.

Machine learning techniques for evaluating a patient's condition improve information finding by allowing users to find related instances, develop normalcy statistics, and detect outliers. Such methods are used for diagnostics or risk analysis having the potential to improve healthcare. The International Society for Biological and Environmental Repositories has made its position in the world as a leader for bio storage technology standardization. To standardize biorepository standards, the College of American Pathologists created the first biorepository accreditation program that complies with severe requirements.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Phase of the Clinical Trial Biorepository & Archiving Solutions Market is expected to Offer the Largest Opportunity?

Phase III clinical trials are expected to account for over 50% of the market in 2020. Clinical trials are often carried out in stages that build on one other. Phase III clinical studies assess the novel treatment's safety and efficacy to the existing level of care. While doctors are unsure whether therapy is superior, research participants are typically assigned to either the conventional or novel treatment at random. When feasible, neither the therapist nor sufferer is aware of which treatment is being administered.

In addition, because of the large number of participants and the duration of the phase, long-term and unusual side effects are more likely to come across. The goal of phase 3 studies is to show and validate that the medicine is a safe, useful, and appropriate cure for the targeted application based on the preliminary data acquired in prior trials. Burjeel Medical City in Abu Dhabi, for instance, is ready to start two Phase 3 clinical studies of Mitapivat, a novel, first-in-class enzyme-activating medication (AG-348).

Which Region is projected to Offer the Largest Opportunity for Clinical Trial Biorepository & Archiving Solutions Market?

In 2021, the global Clinical Trial Biorepository & Archiving Solutions market was dominated by North America. One of the key factors driving the regional market is the increase in the frequency of clinical trials. Besides, the existence of a large number of companies in the industry further paves way for the fast-paced growth of the clinical trial biorepository & archiving solutions market.

Pharma Biotech, a North American Clinical Testing firm, recently announced that it has entered a deal with CCrest Laboratories Inc., allowing it to distribute its GMP MDMA to users in Canada and across the globe through preclinical study in two patent-protected Chemical Entities (NCEs) relying on MDXX category molecules also had initiated at PharmAla's R&D unit, with proof-of-concept studies currently underway at the University of Arkansas School for Medical Sciences in the United States and after Vivo Solutions in Canada.

Asia Pacific is expected to gain significant market share at the fastest rate among regions, throughout the forecast period. For instance, SCG Cell Treatment Pte Ltd ("SCG"), a prominent biotechnology firm located in Singapore, announced that Singapore Health Sciences Authority (HSA) has approved SCG101, an autologous T-cell receptor (TCR) T-cell treatment, for medical studies.

SCG101 has been known to prevent hepatocellular carcinoma (HCC), the most prevalent type of liver cancer, caused by the hepatitis B virus (HBV). Specifically, clinical research is expected to grow at an increasing rate. As per a Pharma IQ poll, 60% of respondents noticed China and India as promising areas for clinical research in the next five years.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Analysis

Which Country Holds the Highest Market Revenue for Clinical Trial Biorepository & Archiving Solutions?

The United States is expected to possess the largest market value of around US$ 5 Bn by the end of 2032. Pharmaceutical firms in the United States invest more heavily in research and development than most other businesses. Clinical research funding by the National Institutes of Health was roughly US$ 17.6 bn US dollars in 2020, as compared to US$ 15 Bn in 2019. As per the National Clinical Studies Registry (NCT), there were roughly 11,865 open clinical studies in various stages for cancer indications in the United States in 2020.

The expanding use of clinical trials Biorepository & Archiving Solutions, as well as the existence of large companies and the availability of modern technology, are boosting the market in the United States. UC San Diego bioengineers and cardiologists have invented a device for mapping irregular heart arrhythmias called Bioengineers V.A. TravalasRE INR for Cardiologists, Inc., the company co-founded by UCSD faculty, created the technology. Its validation study showed the device had an average accuracy of 97.3%.

Category-wise Insights

Why Clinical Products is projected to Witness the Fastest Growth among Clinical Trial Biorepository & Archiving Solutions Types?

Among product types, revenue through Clinical Products is forecasted to grow at the highest CAGR of over 11.9% during 2022-2032. This is because the frequency of clinical trial enrolment has increased over the years. ClinicalTrials.gov stated that 386,583 studies have been recorded in 219 nations as of August 2021, compared to 362,524 tests in 2020 and almost 325,787 tests in 2019. Adding to the development, of Stimwave Technology the level-1 FREEDOM clinical study series which provides multi, progressive, randomized trials that track chronic pain sufferers' reactions to peripheral nerve stimulation (PNS) throughout the years. FREEDOM-1 is Stimwave's first clinical trial evaluating the Stimwave Freedom PNS device for treating patients with persistent knee pain.

Which Application of Clinical Trial Biorepository & Archiving Solutions is expected to Score Highest Growth in the Coming Years?

Revenue through Biorepository Services in Clinical Trial Biorepository & Archiving Solutions is expected to command the largest revenue as well as a CAGR of nearly 12.1%, during the forecast period. Biorepositories are an essential aspect of successful healthcare as they provide tools for translational biomedical research, in vitro technology guidance through the FDA procedures, diagnostic technique testing and evaluation, and customized medication. The Health Insurance Portability and Accountability Act, the Right to Withdraw, the European Union General Data Protection Regulation, and other regulations governing the sample custody and ownership, human tissues, and access to biospecimens are likely to improve data security and patient privacy.

What is the impact of Covid-19 on the Clinical Trial Biorepository & Archiving Solutions Market?

The COVID-19 outbreak posed several hurdles to medical systems, particularly medical research programs in cancer. Oncology clinical trial testing, registration, and study practices suffered significant unfavorable consequences that forced institutional and regulatory agencies to devise novel methods to sustain strong and equal engagement in such studies. In addition, the US Food and Drug Administration's Oncology Centers of Excellence was already engaged in a large number of initiatives to tackle issues for cancer survivors during the COVID-19 epidemic, including publishing guideline manuals and helping to update clinical trials.

The clinical cycle for the patient has been simplified owing to the digital pathology developments at Memorial Sloan Kettering Cancer Center. Pathologists may examine specimens from anywhere since there are pathological labs nearby that can analyze and scan glass slides that decrease risk and keeps the pathology industry in place.

Competitive Analysis

Companies are adopting a variety of tactical methods to improve their services and obtain a competitive edge over their competitors, such as geographical growth, new business contracts, mergers and acquisitions, and partnerships.

Some of the recent developments of key Clinical Trial Biorepository & Archiving Solutions providers are as follows:

  • In January 2020, Brooks Life Sciences expanded the capacity of its Indianapolis biorepository to boost its biobanking and sample management capabilities. Clients in academia and pharma who wanted to speed up clinical studies and find answers benefited from this growth.
  • In March 2020, ATCC has joined hands with the Global Scientific Community. Taking Covid19 into consideration, the collaboration sought to expand its assistance to the US and foreign R&D communities.

Similarly, recent developments related to companies’ Clinical Trial Biorepository & Archiving Solutions services have been tracked by the team at Future Market Insights, which are available in the full report.

Clinical Trial Biorepository & Archiving Solutions Market Report Scope

Attributes Details
Forecast Period 2022 to 2032
Historical Data Available for 2017 to 2021
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, United Arab Emirates(UAE), and Israel.
Key Market Segments Covered Product Type, Phase, Application, Region
Key Companies Profiled
  • Brooks Life Science
  • Patheon
  • Precision for Medicine, Inc.
  • Medpace
  • LabCorp Drug Development
  • ATCC
  • Q2 Solutions
  • Labconnect
  • Charles River Laboratories
  • Cell&Co BioServices
Pricing Available upon Request

Market Segments Covered in Clinical Trial Biorepository & Archiving Solutions Market Analysis

By Product Type:

  • Preclinical Products
  • Clinical Products

By Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Application:

  • Biorepository Services
  • Archiving Solution Services

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa(MEA)

Frequently Asked Questions

How much is the current worth of the Clinical Trial Biorepository & Archiving Solutions Market?

The global Clinical Trial Biorepository & Archiving Solutions Market is worth more than US$ 3.5 Bn at present.

What is the sales forecast for Clinical Trial Biorepository & Archiving Solutions Market?

The value of the Clinical Trial Biorepository & Archiving Solutions Market is projected to increase at a CAGR of around 12.1% from 2022 – to 2032.

What was the last 5 year’s market CAGR?

The value of the Clinical Trial Biorepository & Archiving Solutions Market increased at a CAGR of around 9.9% from 2017 – to 2021.

What is a key trend shaping the growth of the market for the Clinical Trial Biorepository & Archiving Solutions Market?

The key trend driving the market growth are increased R&D investment and the availability of low-cost computers.

At what percentage is sales of Clinical Trial Biorepository & Archiving Solutions Market going to register growth in China?

The market for Clinical Trial Biorepository & Archiving Solutions Market in China is projected to expand at a CAGR of around 15.8% from 2022 – to 2032.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 15.5%, the market in Japan is projected to register a CAGR of nearly 14.8% from 2022 – to 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

4. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Preclinical Products

        5.3.2. Clinical Products

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        6.3.1. Biorepository Services

            6.3.1.1. Warehousing & Storage

            6.3.1.2. Transportation

            6.3.1.3. Sample Processing

            6.3.1.4. Other Biorepository Services

        6.3.2. Archiving Solution Services

            6.3.2.1. Database Indexing and Management

            6.3.2.2. Scanning & Destruction

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Application, 2022-2032

7. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Phase

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Phase, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Phase, 2022-2032

        7.3.1. Phase I

        7.3.2. Phase II

        7.3.3. Phase III

        7.3.4. Phase IV

    7.4. Y-o-Y Growth Trend Analysis By Phase, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Phase, 2022-2032

8. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Application

        9.2.4. By Phase

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Application

        9.3.4. By Phase

    9.4. Key Takeaways

10. Latin America Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Application

        10.2.4. By Phase

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Application

        10.3.4. By Phase

    10.4. Key Takeaways

11. Europe Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. Russia

            11.2.1.7. BENELUX

            11.2.1.8. Rest of Europe

        11.2.2. By Product Type

        11.2.3. By Application

        11.2.4. By Phase

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Application

        11.3.4. By Phase

    11.4. Key Takeaways

12. Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Rest of Asia Pacific

        12.2.2. By Product Type

        12.2.3. By Application

        12.2.4. By Phase

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Application

        12.3.4. By Phase

    12.4. Key Takeaways

13. MEA Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC

            13.2.1.2. Rest of MEA

        13.2.2. By Product Type

        13.2.3. By Application

        13.2.4. By Phase

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Application

        13.3.4. By Phase

    13.4. Key Takeaways

14. Key Countries Clinical Trial Biorepository & Archiving Solutions Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Product Type

            14.1.2.2. By Application

            14.1.2.3. By Phase

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Product Type

            14.2.2.2. By Application

            14.2.2.3. By Phase

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Product Type

            14.3.2.2. By Application

            14.3.2.3. By Phase

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Product Type

            14.4.2.2. By Application

            14.4.2.3. By Phase

    14.5. Argentina

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Product Type

            14.5.2.2. By Application

            14.5.2.3. By Phase

    14.6. Germany

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Product Type

            14.6.2.2. By Application

            14.6.2.3. By Phase

    14.7. Italy

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Product Type

            14.7.2.2. By Application

            14.7.2.3. By Phase

    14.8. France

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Product Type

            14.8.2.2. By Application

            14.8.2.3. By Phase

    14.9. U.K.

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Product Type

            14.9.2.2. By Application

            14.9.2.3. By Phase

    14.10. Spain

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Product Type

            14.10.2.2. By Application

            14.10.2.3. By Phase

    14.11. Russia

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Product Type

            14.11.2.2. By Application

            14.11.2.3. By Phase

    14.12. BENELUX

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Product Type

            14.12.2.2. By Application

            14.12.2.3. By Phase

    14.13. China

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Product Type

            14.13.2.2. By Application

            14.13.2.3. By Phase

    14.14. Japan

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Product Type

            14.14.2.2. By Application

            14.14.2.3. By Phase

    14.15. South Korea

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Product Type

            14.15.2.2. By Application

            14.15.2.3. By Phase

    14.16. India

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Product Type

            14.16.2.2. By Application

            14.16.2.3. By Phase

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Product Type

            14.17.2.2. By Application

            14.17.2.3. By Phase

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Product Type

        15.3.3. By Application

        15.3.4. By Phase

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Brooks Life Science

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segment

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

                16.1.1.5.2. Product Strategy

        16.1.2. Patheon

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segment

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

                16.1.2.5.2. Product Strategy

        16.1.3. Precision for Medicine, Inc.

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segment

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

                16.1.3.5.2. Product Strategy

        16.1.4. Medpace

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segment

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

                16.1.4.5.2. Product Strategy

        16.1.5. LabCorp Drug Development

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segment

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

                16.1.5.5.2. Product Strategy

        16.1.6. ATCC

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segment

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

                16.1.6.5.2. Product Strategy

        16.1.7. Q2 Solutions

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segment

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

                16.1.7.5.2. Product Strategy

        16.1.8. Labconnect

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segment

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

                16.1.8.5.2. Product Strategy

        16.1.9. Charles River Laboratories

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segment

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

                16.1.9.5.2. Product Strategy

        16.1.10. Cell&Co BioServices

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segment

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

                16.1.10.5.2. Product Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Recommendations

Healthcare

Clinical Trial Market

Published : January 2024

Healthcare

Pediatric Clinical Trial Market

Published : January 2024

Healthcare

Clinical Information System Market

Published : June 2022

Explore Healthcare Insights

View Reports

Clinical Trial Biorepository & Archiving Solutions Market